Expand REGN Menu
REGN MENU

REGN Stock Posts


Outlook is neutral, with stock confined to a range of ±2%

Strategy has +63% ROI potential and 20% overvalued

Unusual Option Volume

REGN Regeneron Pharmaceuticals687.19+20.34 (+3.1%)

Regeneron Pharmaceuticals trades 1,552 contracts. The company has the following event: on Apr 18, 2025. News: REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
$REGN Earnings February 04 BMO. Expected Move ±5.7% vs Prev. Move -9.2%
Unusual Option Volume

REGN Regeneron Pharmaceuticals698.62-4.81 (-0.7%)

Regeneron Pharmaceuticals trades 4,155 contracts. REGN will report earnings on Feb 4, 2025. The company has the following event: on Apr 18, 2025. News: Regeneron Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights REGN
Unusual Option Volume

REGN Regeneron Pharmaceuticals682.98-13.90 (-2.0%)

Regeneron Pharmaceuticals trades 1,772 contracts. REGN will report earnings on Feb 4, 2025. The company has the following event: 43rd Annual J.P. Morgan Healthcare Conference on Jan 13, 2025. News: Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report Hagens Berman
Unusual Option Volume

REGN Regeneron Pharmaceuticals741.43+11.13 (+1.5%)

Regeneron Pharmaceuticals trades 3,433 contracts. REGN will report earnings on Feb 4, 2025. The company has the following event: 43rd Annual J.P. Morgan Healthcare Conference on Jan 13, 2025. News: Law Offices of Frank R. Cruz Encourages Regeneron Pharmaceuticals, Inc. (REGN) Investors To Inquire About Securities Fraud Class Action